OPINION: Next Step in Dismantling Obamacare: IPAB

SHIRE: The Swiss Agency for Therapeutic Products (Swissmedic) Validates Shire’s Marketing Authorization Application (MAA) for Investigational Hereditary Angioedema (HAE) Treatment Lanadelumab Apr 22, 2018

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACIST: AHA, ASHP, and FAH Collaborating on Drug-Pricing Survey Apr 22, 2018

SHIRE: Shire Announces Sale of Oncology Business to Servier for $2.4 Billion Apr 22, 2018

AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACIST: New ASHP Certificate Program Offers Sterile Compounding Training for Institutions Apr 22, 2018

MERCK: Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine Apr 22, 2018

ASTRAZENECA PHARMACEUTICALS LP: US FDA approves Tagrisso as 1st-line treatment for EGFR-mutated non-small cell lung cancer Apr 22, 2018

Federal Issues

OPINION: Next Step in Dismantling Obamacare: IPAB Jan 25, 2018

• Novartis's Kymriah approved by FDA to treat acute lymphoblastic leukemia
• BIO praises president's signature of FDA Reauthorization Act
• MedStar Health performs first vBloc implant using VA alternative
• Argentum advances action against Novartis product

Industry News

Pfizer’s FDA-approved Besponsa leukemia drug finds new distributor Jan 25, 2018

• Lannett gains approval for generic Nexium in time-released capsules
• Rite Aid rolls out KidCents Safe Medication Disposal Program
• Novartis's Kymriah approved by FDA to treat acute lymphoblastic leukemia
• Coherus BioSciences reveals positive outcome for biosimilar PK/BE study

Innovation

Pfizer’s FDA-approved Besponsa leukemia drug finds new distributor Jan 25, 2018

• Lannett gains approval for generic Nexium in time-released capsules
• Rite Aid rolls out KidCents Safe Medication Disposal Program
• Ascend Therapeutics, Egalet Corp. offer new opioid-free painkiller delivered via nasal spray
• Endo ships generic Sabril following FDA approval

People

ScriptSave WellRx wins conference product class award Jan 25, 2018

• Rite Aid rolls out KidCents Safe Medication Disposal Program
• Merck and University of Oxford release positive results from REVEAL study of anacetrapib
• Parexel leaders named to 2017 PharmaVOICE's 100 inspiring people
• DelMar Pharmaceuticals adds Zarrabian, Mohr to board

Regulatory

Pfizer’s FDA-approved Besponsa leukemia drug finds new distributor Jan 25, 2018

• Rite Aid rolls out KidCents Safe Medication Disposal Program
• Novartis's Kymriah approved by FDA to treat acute lymphoblastic leukemia
• Coherus BioSciences reveals positive outcome for biosimilar PK/BE study
• Endo ships generic Sabril following FDA approval

State Issues

ScriptSave WellRx wins conference product class award Jan 25, 2018

• Novartis's Kymriah approved by FDA to treat acute lymphoblastic leukemia
• Merck and University of Oxford release positive results from REVEAL study of anacetrapib
• Reduction in antibiotic prescriptions in Massachusetts leads national trend
• UnitedHealthcare grants $234,000 for rural Kansas care